ZA981832B - Swallow tablet comprising paracetamol - Google Patents

Swallow tablet comprising paracetamol

Info

Publication number
ZA981832B
ZA981832B ZA981832A ZA981832A ZA981832B ZA 981832 B ZA981832 B ZA 981832B ZA 981832 A ZA981832 A ZA 981832A ZA 981832 A ZA981832 A ZA 981832A ZA 981832 B ZA981832 B ZA 981832B
Authority
ZA
South Africa
Prior art keywords
paracetamol
swallow tablet
swallow
tablet
Prior art date
Application number
ZA981832A
Other languages
English (en)
Inventor
Timothy James Grattan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA981832B publication Critical patent/ZA981832B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
ZA981832A 1997-03-05 1998-03-04 Swallow tablet comprising paracetamol ZA981832B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9704524.9A GB9704524D0 (en) 1997-03-05 1997-03-05 Composition

Publications (1)

Publication Number Publication Date
ZA981832B true ZA981832B (en) 1998-12-11

Family

ID=10808717

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA981832A ZA981832B (en) 1997-03-05 1998-03-04 Swallow tablet comprising paracetamol

Country Status (35)

Country Link
US (1) US6316025B1 (de)
EP (1) EP0981334B1 (de)
JP (1) JP2001513801A (de)
KR (1) KR100465895B1 (de)
CN (1) CN100389751C (de)
AP (1) AP1084A (de)
AR (1) AR011919A1 (de)
AT (1) ATE240720T1 (de)
AU (1) AU721851B2 (de)
BG (1) BG64348B1 (de)
BR (1) BR9807992A (de)
CA (1) CA2283408C (de)
CO (1) CO4940406A1 (de)
CY (1) CY2367B1 (de)
CZ (1) CZ294078B6 (de)
DE (1) DE69814850T2 (de)
DK (1) DK0981334T3 (de)
EA (1) EA001918B1 (de)
ES (1) ES2199435T3 (de)
GB (1) GB9704524D0 (de)
HU (1) HU224983B1 (de)
ID (1) ID22233A (de)
IL (1) IL131552A (de)
MY (1) MY119722A (de)
NO (1) NO327456B1 (de)
NZ (1) NZ337418A (de)
PE (1) PE68899A1 (de)
PL (1) PL190988B1 (de)
PT (1) PT981334E (de)
SK (1) SK282277B6 (de)
TR (1) TR199902175T2 (de)
TW (1) TW508242B (de)
UA (1) UA59388C2 (de)
WO (1) WO1998038983A2 (de)
ZA (1) ZA981832B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
NZ508291A (en) * 1999-11-24 2002-09-27 Mcneil Ppc Inc Use of acetaminophen in a medicament for treating migraine symptoms
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition
WO2004089365A1 (en) * 2003-04-11 2004-10-21 Pfizer Limited Pharmaceutical combination comprising eletriptan and sodium bicarbonate
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EP1761250A4 (de) * 2004-05-28 2007-05-09 Imaginot Pty Ltd Orales abgabesystem
EP3216445A1 (de) 2004-05-28 2017-09-13 Imaginot Pty Ltd. Abgabesystem für eine orale therapeutische verbindung
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
AU2005302618B2 (en) * 2004-10-28 2009-10-22 Gsk Consumer Healthcare Sarl Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkaline agent for enhanced absorption
US9060950B2 (en) * 2005-06-13 2015-06-23 Paul H. Rosenberg, Proximate Concepts, LLC. Emetic embedded capsule
EP1893183A4 (de) * 2005-06-13 2010-08-18 Paul Rosenberg Emetische eingebettete kapsel
KR100702069B1 (ko) * 2005-10-31 2007-03-30 (주)이엘티사이언스 파라세타몰 경구용 수용산제 복합조성물 및 그 제조방법
EP3263117A1 (de) 2005-11-28 2018-01-03 Imaginot Pty Ltd. Abgabesystem für eine orale therapeutische verbindung
GB0607085D0 (en) 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
EP2043613A1 (de) * 2006-07-14 2009-04-08 Fmc Corporation Feste form
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
ES2424872T3 (es) * 2007-08-07 2013-10-09 Stellenbosch University Paracetamol para su utilización en el tratamiento del glaucoma
KR101687580B1 (ko) 2016-07-19 2016-12-20 주식회사 씨.월드 의자 등받이부와 프레임부 조립구조
BR112021006027A2 (pt) 2018-11-19 2021-06-29 Jazz Pharmaceuticals Ireland Limited formulações de fármaco resistente a álcool

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1182049A (en) * 1981-07-13 1985-02-05 Francis J. Sterbenz Apap antacid composition
ES2060736T3 (es) 1989-01-12 1994-12-01 Bayer Ag Composicion antiacida analgesica efervescente con un contenido en sodio reducido.
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
US5348745A (en) * 1989-05-09 1994-09-20 Miles Inc. Aqueous granulation solution and a method of tablet granulation
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
DE19502789A1 (de) 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel

Also Published As

Publication number Publication date
PE68899A1 (es) 1999-09-26
AR011919A1 (es) 2000-09-13
WO1998038983A2 (en) 1998-09-11
BG64348B1 (bg) 2004-11-30
DE69814850D1 (de) 2003-06-26
EA199900709A1 (ru) 2000-08-28
CA2283408A1 (en) 1998-09-11
BG103714A (en) 2000-05-31
HK1027026A1 (en) 2001-01-05
DE69814850T2 (de) 2004-03-11
EP0981334B1 (de) 2003-05-21
CN100389751C (zh) 2008-05-28
JP2001513801A (ja) 2001-09-04
TR199902175T2 (xx) 1999-12-21
AU6828298A (en) 1998-09-22
CA2283408C (en) 2007-01-02
IL131552A (en) 2004-08-31
EP0981334A1 (de) 2000-03-01
EA001918B1 (ru) 2001-10-22
TW508242B (en) 2002-11-01
CZ294078B6 (cs) 2004-09-15
KR20000075897A (ko) 2000-12-26
KR100465895B1 (ko) 2005-01-13
HUP0001501A2 (hu) 2000-09-28
NO327456B1 (no) 2009-07-06
CY2367B1 (en) 2004-06-04
US6316025B1 (en) 2001-11-13
ATE240720T1 (de) 2003-06-15
CZ314899A3 (cs) 2000-03-15
BR9807992A (pt) 2000-03-08
NZ337418A (en) 2000-05-26
CN1253497A (zh) 2000-05-17
SK282277B6 (sk) 2002-01-07
ES2199435T3 (es) 2004-02-16
CO4940406A1 (es) 2000-07-24
HUP0001501A3 (en) 2001-01-29
NO994294D0 (no) 1999-09-03
ID22233A (id) 1999-09-23
SK119799A3 (en) 2000-02-14
MY119722A (en) 2005-07-29
PL335502A1 (en) 2000-04-25
IL131552A0 (en) 2001-01-28
AU721851B2 (en) 2000-07-13
UA59388C2 (uk) 2003-09-15
AP9901638A0 (en) 1999-09-30
NO994294L (no) 1999-09-03
DK0981334T3 (da) 2003-09-22
PL190988B1 (pl) 2006-02-28
PT981334E (pt) 2003-10-31
WO1998038983A3 (en) 1998-12-17
AP1084A (en) 2002-07-23
HU224983B1 (en) 2006-05-29
GB9704524D0 (en) 1997-04-23

Similar Documents

Publication Publication Date Title
PL340337A1 (en) Drugs
AP9901638A0 (en) Swallow tablet comprising paracetamol
ZA987551B (en) Solid pharmaceutical dosage forms
GB9814501D0 (en) Medication dosage reminder device
AU134671S (en) Pacifier
IL146632A0 (en) Pharmaceutical tablets
ZA9811504B (en) Novel pharmaceutical.
AU141186S (en) Tablet
GB9726566D0 (en) Novel pharmaceutical
EP1145714A4 (de) Arzneimittel
EG23694A (en) Novel pharmaceutical
IL121696A0 (en) Pacifier
GB9725219D0 (en) Tablets
SI0981334T1 (en) Swallow tablet comprising paracetamol
GB9706376D0 (en) Novel pharmaceutical
CA80343S (en) Pharmaceutical tablet
CA83558S (en) Pharmaceutical tablet
CA84666S (en) Pharmaceutical tablet
CA80449S (en) Tablet
CA80450S (en) Tablet
CA80217S (en) Tablet
AU134179S (en) Tablet
AU134228S (en) Tablet
GB9717420D0 (en) Pill monitor
GB9725661D0 (en) Ptient-prompted medication